QT
MLTX icon

Quantbot Technologies’s MoonLake Immunotherapeutics MLTX Stock Holding History

Quantbot Technologies’s Portfolio MLTX Stock Details MLTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$541K Buy
27,807
+27,708
+27,988% +$502K 0.02% 884
2026
Q1 		$1.84K Sell
99
-6,167
-98% -$102K ﹤0.01% 1610
2025
Q4 		$82.6K Buy
+6,266
New +$73.9K ﹤0.01% 1452
2025
Q3 		– Sell
-49
Closed -$2.31K – 1983
2025
Q2 		$2.31K Buy
+49
New +$2K ﹤0.01% 1572

Other funds holding MLTX

BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return
WAM
Weiss Asset Management Boston, Massachusetts $9.54B AUM 55.06% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Quantbot Technologies's MLTX Position: Q2 2026 in Review

Quantbot Technologies increased its MoonLake Immunotherapeutics (MLTX) stake by 27,988% in Q2 2026, buying an estimated $502K and bringing the position to 27,807 shares worth $541K. The position accounts for 0.02% of the portfolio, ranked #884.

Quantbot Technologies first reported a position in MLTX in Q2 2025 and has held it in 4 quarters since. 173 funds tracked by Wall St. Rank hold MLTX as of Q2 2026.

  • Quantbot Technologies held 27,807 shares of MoonLake Immunotherapeutics worth $541K as of Q2 2026.
  • Quantbot Technologies bought 27,708 MoonLake Immunotherapeutics shares in Q2 2026, an estimated $502K.
  • MoonLake Immunotherapeutics made up 0.02% of Quantbot Technologies's portfolio in Q2 2026, its #884 holding.
  • Quantbot Technologies first reported a position in MoonLake Immunotherapeutics in Q2 2025 and has held it in 4 quarters since.
  • 173 funds tracked by Wall St. Rank held MoonLake Immunotherapeutics as of Q2 2026.

Based on Quantbot Technologies's 13F filing for Q2 2026, filed 12 Aug 2026.